DUBLIN–(BUSINESS WIRE)–The “Hepatitis B Vaccines: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
Global Hepatitis B Vaccines Market to Reach $3.4 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Hepatitis B Vaccines estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at a CAGR of 3.9% over the analysis period 2020-2027. Combination Vaccines, one of the segments analyzed in the report, is projected to record 4.4% CAGR and reach US$2.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Mono Vaccines segment is readjusted to a revised 3.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $715.6 Million, While China is Forecast to Grow at 6.5% CAGR
The Hepatitis B Vaccines market in the U.S. is estimated at US$715.6 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$668.6 Million by the year 2027 trailing a CAGR of 6.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.
Select Competitors (Total 14 Featured) –
- Beijing Minhai Biotechnology Co., Ltd.
- Bharat Biotech International Ltd.
- Binnopharm Group LLC
- Biokangtai
- CSL Ltd.
- Dynavax Technologies Corporation
- Emergent BioSolutions, Inc.
- GlaxoSmithKline PLC
- Hualan Biological Engineering Co., Ltd.
- Merck & Co., Inc.
What’s New for 2022?
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies – Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- Hepatitis B Vaccines – Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
Companies Mentioned
- Beijing Minhai Biotechnology Co., Ltd.
- Bharat Biotech International Ltd.
- Binnopharm Group LLC
- Biokangtai
- CSL Ltd.
- Dynavax Technologies Corporation
- Emergent BioSolutions, Inc.
- GlaxoSmithKline PLC
- Hualan Biological Engineering Co., Ltd.
- Merck & Co., Inc.
For more information about this report visit https://www.researchandmarkets.com/r/oixc6p
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900